高齢者におけるBMIと転倒リスクに関する年齢との相互作用
Filipe Rodrigues1,2, Diogo Monteiro1,2, António Miguel Monteiro3,4
1ESECS-Polytechnic of Leiria, 2411-901 Leiria, Portugal.
Epidemiologia (Basel, Switzerland)
|February 20, 2026
まとめ
肥満は60歳から79歳までの高齢者の転倒リスクを高めます. しかし,80歳以上の場合,通常の体重は,潜在的な筋肉喪失 (サルコペニア) に起因する転倒から保護しない可能性があります.
科学分野:
- ゲロントロジーはゲロントロジーの学科です.
- 公衆衛生は公衆衛生である.
- キネシオロジー キネシオロジー
背景:
- 老化は,機能的フィットネスの低下と,転倒の可能性の増加と関連しています.
- 肥満は,移動能力の低下の既知の要因ですが,老化と転倒リスクとの相互作用については,さらなる研究が必要です.
- これらの関係を理解することは,高齢者の転倒予防に不可欠です.
研究 の 目的:
- コミュニティに住む高齢者の転倒リスクに対する年齢,性別,体量指数 (BMI) の影響の組み合わせを調査する.
- 落下リスクが著しく高い特定の年齢層やBMIカテゴリーを特定する.
- サルコペニアなどの潜在的メカニズムを探求し,老年期における転倒リスクに貢献する.
主な方法:
- 815人の高齢者 (平均年齢70.45歳) を対象とした横断的な研究.
- 参加者は年齢 (60代,70代,80代) とBMI (正常,過体重,肥満) によって層格化されました.
- 転落リスクは,タイムアップ&ゴーテストを使用して測定され,三方向ANOVAで分析されました.
主要な成果:
- 年齢,性別,BMIの間の有意な相互作用は見つかりませんでしたし,転落リスクに対する性別の主な影響も見つかりませんでした.
- 年齢とBMIの間の有意な相互作用が観察されました (p=0.007).
- 肥満は,正常体重と比較して,60代と70代で転倒のリスクを大幅に増加させたが,80代ではそうではなかった.
結論:
- 肥満は60歳から79歳の成人の転倒リスク要因の1つです.
- "体重パラドックス"は,通常の体重が保護を提供しない80代に存在し,おそらくはサルコペニアによるものです.
- 年齢に合わせた転倒リスク評価と体重管理を推奨し,高齢者の筋肉質の保全を強調しています.
関連する概念動画
Drug Dosing: Geriatric Patients
308
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
308
Pharmacodynamics in Geriatric Patients: Effects of Age
257
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
257
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
287
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
287
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
249
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
249
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
274
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
274
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
748
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
748


